Roger Bloxham

Background

Roger Bloxham is the managing director of Ferndale Pharmaceuticals Ltd (Ferndale Pharma). He has a BSc (Hons) in Applied Biology and is a fellow of the Royal Society of Biology. He has been involved in the pharmaceutical and life science industries for over 30 years, focusing on dermatological and topical medicines and cosmetic dermatological skincare for the last 20-plus years.

Ferndale Pharma is the exclusive UK partner for Cantabria Labs, Spain, and has operated their business in the UK since 2008. Cantabria Labs is a pharmaceutical and dermatological skincare research, development and manufacturing company. Their portfolio includes the Heliocare very high-level sun protection range. More information about the UK activity can be found at cantabrialabs.co.uk.